Skip to main content

MW 583.6 Da. Inhibits β-Lactamase. Timentin (Ticarcillin Disodium Salt/Potassium Clavulanate) is highly effective against gram negative bacteria such as Agrobacterium strains.

Be the first to review this product! Submit a review

Key facts

CAS number
86482-18-0
Form
Solid
Molecular weight
583.6 Da
Molecular formula
C23H25N3O11S2
PubChem identifier
6437075
Nature
Synthetic

Alternative names

Recommended products

MW 583.6 Da. Inhibits β-Lactamase. Timentin (Ticarcillin Disodium Salt/Potassium Clavulanate) is highly effective against gram negative bacteria such as Agrobacterium strains.

Key facts

PubChem identifier
6437075
Solubility

H2O.

Biochemical name
Ticarcillin-clavulanic acid
Biological description

Inhibits β-Lactamase. Timentin (Ticarcillin Disodium Salt/Potassium Clavulanate) is highly effective against gram negative bacteria such as Agrobacterium strains.

Canonical SMILES
CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CSC=C3)C(=O)O)C(=O)O)C.C1C2N(C1=O)C(C(=CCO)O2)C(=O)O
Isomeric SMILES
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CSC=C3)C(=O)O)C(=O)O)C.C1[C@@H]2N(C1=O)[C@H](/C(=C/CO)/O2)C(=O)O
InChI
InChI=1S/C15H16N2O6S2.C8H9NO5/c1-15(2)9(14(22)23)17-11(19)8(12(17)25-15)16-10(18)7(13(20)21)6-3-4-24-5-6;10-2-1-4-7(8(12)13)9-5(11)3-6(9)14-4/h3-5,7-9,12H,1-2H3,(H,16,18)(H,20,21)(H,22,23);1,6-7,10H,2-3H2,(H,12,13)/b;4-1-/t7-,8-,9+,12-;6-,7-/m11/s1
InChIKey
XWMVMWTVLSLJGY-FAJPTIRJSA-N
IUPAC name
(2S,5R,6R)-6-[[(2R)-2-carboxy-2-thiophen-3-ylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;(2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

Storage

Shipped at conditions
Blue Ice
Appropriate long-term storage conditions
+4°C
Storage information
It is important to note that this is air sensitive and impurities can occur as a result of air oxidation, Store under desiccating conditions

Notes

This product is manufactured by BioVision, an Abcam company and was previously called B1508 Timentin. B1508-25g is the same size as the 25 g size of ab285427.

Do not take internally. Wear gloves and mask when handling.

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.
Activity summary

Beta-lactamase is an enzyme responsible for breaking down beta-lactam antibiotics such as penicillins and cephalosporins. This enzyme is also known by several names: beta lactamase beta-lactamase and b-lactamase. It has a molecular weight of approximately 29 kDa. Mainly beta-lactamase is expressed in various bacterial species including Escherichia coli and Staphylococcus aureus where it provides them with resistance against beta-lactam antibiotics. The presence of beta-lactamase significantly impacts the efficacy of these antibiotics in clinical settings.

Biological function summary

Beta-lactamase enzymes interact with beta-lactam antibiotics by hydrolyzing the beta-lactam ring within the antibiotic molecule. This action prohibits the antibiotics from binding to their bacterial targets rendering them ineffective. Beta-lactamase does not function alone; it can associate with other proteins in bacteria such as the outer membrane proteins which facilitate its secretion and activity. This enzyme is not part of a larger complex but works independently to confer antibiotic resistance to the host organism.

Pathways

Beta-lactamase plays a critical role in the antibiotic resistance pathway. This enzyme links to the cell wall biosynthesis pathway by inhibiting antibiotics that target bacterial cell wall synthesis. Because of this inhibition the production of cell wall components continues unhindered. Beta-lactamase activity is associated with penicillin-binding proteins (PBPs) which are the intended targets of beta-lactam antibiotics. By preventing the binding of antibiotics to these PBPs beta-lactamase ensures the survival of resistant bacterial strains.

Associated diseases and disorders

Beta-lactamase contributes significantly to antibiotic resistance leading to infections that are difficult to treat such as methicillin-resistant Staphylococcus aureus (MRSA) and multidrug-resistant Escherichia coli infections. These bacteria produce beta-lactamase neutralizing the therapeutic effects of many commonly used antibiotics. The enzyme's action connects it to other proteins involved in resistance mechanisms like efflux pumps and proteases which also play parts in shielding bacteria from antibacterial agents. This correlation underlines the necessity for developing inhibitors that target beta-lactamase without hindering beneficial bacterial functions.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

0 product images

    Downloads

    Product protocols

    For this product, it's our understanding that no specific protocols are required. You can:

    Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

    For licensing inquiries, please contact partnerships@abcam.com